CLINICAL_TRIALS
trial_result
· 2010-02-17
Clinical Trial Update: Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body [Phase 1]
Summary
Phase 1 pharmacokinetic study evaluating whether cimetidine affects the elimination of Pfizer's PD-0332334; the trial was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Generalized Anxiety Disorder | Phase 1 | Status: TERMINATED